High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
about
IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1βA child with resistant Kawasaki disease successfully treated with anakinra: a case report.Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis.Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm.Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis.IL-1 Inhibition May Have an Important Role in Treating Refractory Kawasaki Disease.Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.Kawasaki disease: insights into pathogenesis and approaches to treatment.Clinical features and correct diagnosis of macrophage activation syndrome.The Clinical Diagnosis and Management of Kawasaki Disease: a Review and Update.Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.How to Treat Involvement of the Central Nervous System in Hemophagocytic Lymphohistiocytosis?Effect and Safety of TNF Inhibitors in Immunoglobulin-Resistant Kawasaki Disease: a Meta-analysis.Treatment Options for Resistant Kawasaki Disease.Controversies in diagnosis and management of Kawasaki disease.Adeno-associated Virus Vector-mediated Interleukin-10 Induction Prevents Vascular Inflammation in a Murine Model of Kawasaki Disease.TNF-α blockers for the treatment of Kawasaki disease in children
P2860
Q36326783-E46D83E6-E084-40C8-AE5A-6234942A6425Q36340938-541E022D-5152-41BD-B333-5BFF45087015Q36793618-E404DEF2-AE4D-470F-B1C3-D23FC9CABC7DQ36849601-1EB5A80E-99D0-4FB8-B04A-03D2B3F75ED8Q37364378-186E3B1F-BAE1-4B7D-9DC5-E2B2F2128564Q37572983-62377C1A-9BD1-48A5-92E1-414B7F12AA48Q37620412-D44717D9-DE1A-4C54-8D31-DEB975CA2D4FQ37723505-346A82FB-1BEF-4941-9D5A-191BED8C1478Q37735696-49AE2987-B377-4861-8542-E98CEA8D9500Q38439648-736B7C2B-44C6-4BC3-8D76-7F548DD91E69Q38530013-ECE00CF6-300C-47BD-9FCA-2A961B91D621Q38967070-60C9A28E-5D89-40A3-92A0-DF4AA3C211ABQ38993829-7794EA96-AE82-4447-B90C-EA561E930559Q39117038-C798BD76-3E38-4493-A8BE-83792B7D46AEQ40091671-CD608083-7B40-40C8-B51B-7D1741CDA9FBQ47660588-949F6F4A-5C8D-4AE8-A21D-ED04CE994F9CQ49873428-C9C3F0D8-6D5E-46BA-ADC4-BC919447FCB6Q53681768-16B7F282-C9EB-4112-ABB8-723770758249Q56759657-ED8ADF53-909A-41E8-B215-6BCDAFD551A5
P2860
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
@ast
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
@en
type
label
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
@ast
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
@en
prefLabel
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
@ast
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.
@en
P2860
P356
P1476
High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report
@en
P2093
Ashley Shafferman
James D Birmingham
P2860
P2888
P356
10.1186/1546-0096-12-26
P577
2014-07-11T00:00:00Z
P5875
P6179
1023157458